Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method
Responsible Communication: Scientists and researchers have a responsibility to communicate findings accurately, without sensationalism or implying therapeutic use for research-grade compounds
Analysis is ongoing to compare differences in weight loss, lean mass, and fat mass reduction between those using tirzepatide and those using semaglutide
CALDAG-GEF1 (Ca 2+ and diacylglycerol-regulated guanine nucleotide exchange factor1
US$ 22.98
US$ 26.65
US$ 20.26
US$ 24.86
